首页>
外国专利>
Use of a compound derived from nitrocatecol, catechol-o-methyltransferase inhibitor for the Prevention and / or treatment of a transthyretin related Amyloidosis
Use of a compound derived from nitrocatecol, catechol-o-methyltransferase inhibitor for the Prevention and / or treatment of a transthyretin related Amyloidosis
It is provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis. It is also provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis in combination therapy with another COMT inhibitor, a benzoxazole derivative, iododiflunisal, diflunisal, resveratrol, tauroursodeoxycholic acid, doxocycline, or epigallocatechin-3-gallate.
展开▼